drugset / Trial / NCT00043901

Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

NCT00043901

Phase 4 Completed 141 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of an investigational new drug for supplemental therapy in subjects with primary generalized tonic-clonic (PGTC) seizures.

Timeline

Start
2000-12-01
Primary completion
2003-11-01
Completion
2005-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule